Pro-xylane
CAS No. 439685-79-7
Pro-xylane ( Hydroxypropyl tetrahydropyrantriol )
Catalog No. M21826 CAS No. 439685-79-7
Pro-xylane (Hydroxypropyl tetrahydropyrantriol) is a biologically active C-glycoside in aqueous media, acts as an activator of glycosaminoglycans (GAGs) biosynthesis.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 45 | In Stock |
|
50MG | 59 | In Stock |
|
100MG | Get Quote | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePro-xylane
-
NoteResearch use only, not for human use.
-
Brief DescriptionPro-xylane (Hydroxypropyl tetrahydropyrantriol) is a biologically active C-glycoside in aqueous media, acts as an activator of glycosaminoglycans (GAGs) biosynthesis.
-
DescriptionPro-xylane (Hydroxypropyl tetrahydropyrantriol) is a biologically active C-glycoside in aqueous media, acts as an activator of glycosaminoglycans (GAGs) biosynthesis. Pro-xylane is the first example of 'Green' chemical used in cosmetic.
-
SynonymsHydroxypropyl tetrahydropyrantriol
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number439685-79-7
-
Formula Weight192.21
-
Molecular FormulaC8H16O5
-
Purity>98% (HPLC)
-
SolubilityH2O : 250 mg/mL (1300.66 mM; Need ultrasonic);DMSO : ≥ 83.33 mg/mL (433.54 mM)
-
SMILESCC(O)C[C@H]1[C@@H]([C@H]([C@H](O)CO1)O)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Cavezza A, et al. Synthesis of Pro-Xylane: a new biologically active C-glycoside in aqueous media. Bioorg Med Chem Lett. 2009 Feb 1;19(3):845-9.
molnova catalog
related products
-
Isospinosin
The leaves of Crataegus pinnatifida Bunge.
-
Steviol-?19-?O-?gluc...
Steviol-?19-?O-?glucoside is a natural product from the steviol glycosides biosynthesis pathway in Stevia rebuadiana.
-
Brilliant Blue FCF
Brilliant blue FCF is a nontoxic dye for saphenous vein graft marking that abrogates response to injury.